Prostaglandins antagonistically control Bax activation during apoptosis

Area of Science:

• Cell Biology
• Molecular Biology
• Biochemistry

Background:

• The Bcl-2-associated X protein (Bax) is crucial for apoptosis, activating in early stages and translocating to mitochondria.
• Mechanisms controlling Bax activation, particularly its early stages, remain incompletely understood.

Purpose of the Study:

• To investigate the role of bioactive lipids, specifically prostaglandins, in regulating Bax-dependent apoptosis.
• To elucidate the molecular mechanism by which prostaglandins influence Bax activation and subsequent cell death.

Main Methods:

• Investigated the interaction of prostaglandins (PGE2, PGA2, PGD2) with Bax protein.
• Assessed the impact of prostaglandins on Bax conformation and apoptotic signaling.
• Utilized various cell lines and apoptosis-inducing treatments (staurosporine, UV-B).

Main Results:

• Prostaglandin E2 (PGE2) and its derivative PGA2 bind to Bax, inducing conformational changes and triggering apoptosis.
• A specific cysteine residue, Cys126, in Bax is critical for this prostaglandin-induced activation.
• Prostaglandin D2 (PGD2) inhibits PGE2 binding to Bax and subsequent apoptosis, as well as other apoptosis-inducing stimuli.
• Apoptosis induced by staurosporine and UV-B correlates with increased PGE2 levels.

Conclusions:

• The balance between PGE2 and PGD2 represents a novel early regulatory mechanism for Bax activation during apoptosis.
• Prostaglandins directly modulate Bax activity, offering a new perspective on apoptosis control pathways.
• This prostaglandin-mediated pathway is distinct from, but cooperative with, pathways involving BH3-only proteins like Bid.